Some pre-existing conditions matter a lot more when assessing COVID-19 outcomes
Can't see this email? View it online
   
  Alzheimer's Disease  
  The latest Alzheimer's disease news from News Medical  
 Study: One-third of Alzheimer’s disease family caregivers experience persistent depression symptomsStudy: One-third of Alzheimer’s disease family caregivers experience persistent depression symptoms
 
More than 60% of family caregivers of individuals with Alzheimer’s disease (AD) experienced at least mild depressive symptoms already at the time the individual with AD was diagnosed. In one third of them, depressive symptoms worsened during a five-year follow-up.
 
 
 Some pre-existing conditions matter a lot more when assessing COVID-19 outcomesSome pre-existing conditions matter a lot more when assessing COVID-19 outcomes
 
A new paper in Biology Methods & Protocols, published by Oxford University Press, indicates that some pre-existing conditions-;including degenerative neurological diseases, dementia, and severe disabilities-;matter a lot more than once thought when assessing who is at risk for death due to COVID-19.
 
   Cycles of fasting-mimicking diet appear to reduce signs of Alzheimer’s in miceCycles of fasting-mimicking diet appear to reduce signs of Alzheimer’s in mice
 
Cycles of a diet that mimics fasting appear to reduce signs of Alzheimer's in mice genetically engineered to develop the illness, according to a new USC Leonard Davis School of Gerontology-led study.
 
   High blood pressure causes faster cognitive decline, new study findsHigh blood pressure causes faster cognitive decline, new study finds
 
People with high blood pressure levels face a faster erosion of their ability to think, make decisions and remember information than those with normal blood pressure levels, a new study finds.
 
 Treatment for neurological diseases often no longer effective enough in the later stages
 
Treatment for neurological diseases often no longer effective enough in the later stagesNeurological diseases often begin with an inflammatory process and the degradation of the so-called myelin layer, which surrounds the nerve fibers (axons) like a protective insulating layer.
 
 
 Scientists find new piece of the puzzle in understanding how the brains of Alzheimer's patients work
 
Scientists find new piece of the puzzle in understanding how the brains of Alzheimer's patients workWhy does it become harder to concentrate when you have Alzheimer's disease? The explanation is perhaps that the signals transmitted from glial cells to nerve cells are disrupted.
 
 
 Researchers find link between metabolism and dementia-related brain measures
 
Researchers find link between metabolism and dementia-related brain measuresEvery three seconds, someone in the world is diagnosed with dementia. And while there is no known cure, changes in the brain can occur years before a dementia diagnosis.
 
 
 Increased risk for all-cause dementia in people who abstain from alcohol
 
Increased risk for all-cause dementia in people who abstain from alcoholAlcohol abstinence increases the risk for dementia in later life, according to a recent study published in the journal Addiction. Furthermore, neuroimaging records suggest that even low alcohol consumption levels could harm brain health, as does the dose-response relationship between alcohol use and systemic diseases, such as metabolic diseases and certain cancers.
 
 
 Artificial intelligence used to predict hospitalization outcomes of geriatric patients with dementia
 
Artificial intelligence used to predict hospitalization outcomes of geriatric patients with dementiaBy using artificial intelligence, Houston Methodist researchers are able to predict hospitalization outcomes of geriatric patients with dementia on the first or second day of hospital admission.
 
 
 What are the neuropsychiatric effects of SARS-CoV-2 infection?
 
What are the neuropsychiatric effects of SARS-CoV-2 infection?Researchers investigated cognitive deficits associated with acute SARS-CoV-2 infection.
 
 
 Researchers compare end-of-life care in persons with and without dementia
 
Researchers compare end-of-life care in persons with and without dementiaResearchers have known that race and ethnicity play a role in the intensity of medical care at the end of life, but the difference is more pronounced among individuals with dementia, the researchers found.
 
 
 New algorithm may help predict the risk of Alzheimer's dementia
 
New algorithm may help predict the risk of Alzheimer's dementiaWhen people participate in studies of aging, they often want to know what their individual risks of developing dementia from Alzheimer's disease are. Washington University researchers have developed an algorithm that can help provide them with information about what their risks may be.
 
 
 UW joins the Alliance for Therapies in Neuroscience to transform the fight against neurological diseases
 
UW joins the Alliance for Therapies in Neuroscience to transform the fight against neurological diseasesThe University of Washington has joined the Alliance for Therapies in Neuroscience (ATN), a long-term research partnership between academia and industry geared to transform the fight against brain diseases and disorders of the central nervous system.
 
 
 Study aims to understand how SARS-CoV-2 affects the brain long-term
 
Study aims to understand how SARS-CoV-2 affects the brain long-termResearchers formulate a method to identify the molecular and systemic factors linking COVID-19 to short- and long-term neurologic illness.
 
 
 Brain stimulation combined with nasal spray containing nanoparticles can improve stroke recovery
 
Brain stimulation combined with nasal spray containing nanoparticles can improve stroke recoveryIn a recent study, researchers from Xi'an Jiaotong-Liverpool University and other universities in China have reported that brain stimulation combined with a nose spray containing nanoparticles can improve recovery after ischemic stroke in an animal model.
 
 
 SARS-CoV-2-encoded protein ameliorates neuromuscular degeneration in fly models of neurodegenerative diseases
 
SARS-CoV-2-encoded protein ameliorates neuromuscular degeneration in fly models of neurodegenerative diseasesResearchers explored the in vivo efficacy of SARS-CoV-2-encoded proteins against neuromuscular degeneration associated with ribosome stalling.